KENT, ENGLAND, Ixchelsis plans to develop to proof-of-concept, IX-01, an investigational compound, originally discovered at Pfizer's, Sandwich, UK, R&D site, with the potential to treat the male sexual health indication, premature ejaculation.
Read More